SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurogen (NRGN)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
523 35 0 NRGN
Emcee:  Terry McCormick Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
98 That's interesting. Sounds like a small molecule. Anxiety or epilepsy drug?kathleen-8/14/1997
97 Certain fused pyrrolecarboxanilides, a new class of GABA brain receptor ligandphbolton-8/13/1997
96biz.yahoo.comkathleen-7/31/1997
95 Thanks for the information. Sure sounds like in the past few months we have hadJusta Werkenstiff-7/25/1997
94 FWIW: two, 200,000 share trades today to account for almost all of the volume wphbolton-7/24/1997
93 I can't answer your second question, and my answer to the first would not hscaram(o)uche-7/15/1997
92 Last November, NGD 91-1 was dropped due to "formulation" problems. WThomas M.-7/13/1997
91 The float keeps getting smaller. Four Partners increases stake by 200,000 sharThomas M.-7/13/1997
90 Thomas: I have absolutely no idea. There was no news, the volume was low.... phbolton-7/1/1997
89 What the heck happened today? Down 2 5/8 to 20 1/8. TomThomas M.-7/1/1997
88 Here is a brief discussion of competing obesity drug research, including NPY, bThomas M.-6/30/1997
87 Volume picked up today. TomThomas M.-6/26/1997
86 Looks like there was an "afterhours" trade in NRGN to push it from 21phbolton-6/24/1997
85 Regarding TA, I try to stay within my bounds, i.e. keep it simple. It seems NRThomas M.-6/24/1997
84 Bonus round...... well, _formally_, it'll be NRGN ------> Tularik for scaram(o)uche-6/24/1997
83 Tularik does seem to have a good group of people and it seems to be a good matcphbolton-6/24/1997
82 Tularik is very well thought of, this is very good. BRANFORD, Conn., and SOUceleryroot.com-6/24/1997
81 Thomas: you may be right. I tend not to put much credence in TA but the fact phbolton-6/23/1997
80 NRGN is challenging 20. If it hits 21, then I think we are finally going to seThomas M.-6/22/1997
79 Neurogen Announces IND Filing of New Anxiolytic Candidate, NGD 91-2 Jun 19 199phbolton-6/19/1997
78 Thanks for your information-packed response. Rickscaram(o)uche-6/19/1997
77 That would be an overly lengthy response, since the last time NeuroInvestment rNeuroInvestment-6/18/1997
76 re: exchange2000.com Perhaps you have answered my question. I would greatly aThomas M.-6/18/1997
75 A few comments: 1) NGD-95-1 is promising and Pfizer would not be proceeding if NeuroInvestment-6/17/1997
74 Thanks for the info. What is the time line for the phase II of NGD 95-1? YourPseudo Biologist-6/16/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News